ONCORESPONSE, INC
Profile
Company Names
ONCORESPONSE, INC
ONCORESPONSE INC
Addresses
609 MAIN STREET, SUITE 4200, HOUSTON, TX 77002
909 FANNIN STREET, SUITE 2100, HOUSTON, TX 77010
1124 COLUMBIA STREET, SUITE 300, SEATTLE, WA 98104
Phone Numbers
(206) 805-1600
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2015
State Incorporated:
DELAWARE
Total Amount Raised:
$109,039,285.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2025-04-21
$5,999,138.00
INDEFINITE
INDEFINITE
Equity
4
2023-05-01
$13,915,153.00
$40,000,000.00
$26,084,847.00
Equity
3
2021-03-17
$40,625,995.00
$60,000,000.00
$19,374,005.00
Equity
2
2018-08-23
$18,999,999.00
$39,999,995.00
$20,999,996.00
Equity
1
2015-09-30
$29,499,000.00
$34,044,454.00
$4,545,454.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
CAROL
GALLAGHER
DIRECTOR
CALISTOGA PHARMACEUTICALS INC
| ANAPTYSBIO INC
| ARAGON PHARMACEUTICALS, INC.
| ATTEROCOR, INC.
| SANTA MARIA BIOTHERAPEUTICS, INC.
| PINTA BIOTHERAPEUTICS, INC.
| NINA BIOTHERAPEUTICS, INC.
| CLEAVE BIOSCIENCES, INC.
| MILLENDO THERAPEUTICS, INC.
| METACRINE, INC.
| PIONYR IMMUNOTHERAPEUTICS, INC.
| ANNEXON, INC.
| QPEX BIOPHARMA, INC.
| CHROMACODE, INC.
| ASSABET VALLEY BANCORP
| TREX HOLDINGS INC.
| ONCORESPONSE, INC
STEVE
GILLIS
DIRECTOR
XORI CORP
| ONCOFACTOR CORP
| VARIATION BIOTECHNOLOGIES (US), INC.
| LYCERA CORP
| VBI VACCINES INC.
| ONCORESPONSE INC
| LODO THERAPEUTICS CORP
| PETRA PHARMA CORP
| APOGEN BIOTECHNOLOGIES, INC.
| RODEO THERAPEUTICS CORP
| PRONIRAS CORP
| MAGNOLIA NEUROSCIENCES CORP
| VBI VACCINES INC/BC
| ALLY THERAPEUTICS, INC.
| SKYLARK BIO, INC.
| BASKING BIOSCIENCES, INC.
STEVEN
GILLIS
DIRECTOR
TRUBION PHARMACEUTICALS, INC
| PHASERX INC
| PULMATRIX INC
| THERACLONE SCIENCES, INC.
| MIRINA CORP
| SURFACE LOGIX INC
| ACYLIN THERAPEUTICS, INC.
| BLUEBIRD BIO, INC.
| VARIATION BIOTECHNOLOGIES (US), INC.
| GROOVE BIOPHARMA CORP
| ALLOZYNE INC
| PHASERX, INC.
| VIRAL LOGIC SYSTEMS TECHNOLOGY CORP
| FARADAY PHARMACEUTICALS, INC.
| PULMATRIX OPERATING COMPANY, INC.
| LYCERA CORP
| PULMATRIX, INC.
| NEXGENIA INC.
| CODIAK BIOSCIENCES, INC.
| VBI VACCINES INC/BC
| NOHLA THERAPEUTICS INC.
| HOMOLOGY MEDICINES, INC.
| IMMUSANT, INC.
| ONCORESPONSE INC
| EGENESIS, INC.
| ARCH VENTURE FUND X, L.P.
| ARCH VENTURE FUND X OVERAGE, L.P.
| ARCH VENTURE FUND XI, L.P.
| HC BIOSCIENCE, INC.
| ARCH VENTURE FUND XII, L.P.
| PHEAST THERAPEUTICS, INC.
| SONOTHERA, INC.
| PRONIRAS CORP
| ONCORESPONSE, INC
WENDE
HUTTON
DIRECTOR
TRANSCEND MEDICAL INC
| APIERON INC
| CALIBRA MEDICAL, INC.
| THERACLONE SCIENCES, INC.
| REVISION OPTICS INC
| ALTHEOS, INC.
| ALDEA PHARMACEUTICALS, INC.
| MATURE WOMEN-S HEALTH SOLUTIONS, INC.
| DERMIRA, INC.
| LABRYS BIOLOGICS, INC.
| BUTTERFLY HEALTH, INC.
| CHRONO THERAPEUTICS INC.
| MINIMALLY INVASIVE DEVICES INC.
| HERA THERAPEUTICS INC.
| ONCORESPONSE INC
| HYALEX ORTHOPAEDICS, INC.
| QLARIS BIO, INC.
| STARGAZER PHARMACEUTICALS, INC.
| GLOOKO, INC.
| ALCHERA INC
| ANTIVA BIOSCIENCES, INC.
| ONCORESPONSE, INC
TED
KOUTOUZIS
DIRECTOR
SEAN
MCCARTHY
DIRECTOR
JOHN
MCKEARN
DIRECTOR
ANDREW
PERLMAN
DIRECTOR
VRINGO INC
| COSKATA INC
| TIGERCAT PHARMA, INC.
| AMP AMERICAS, LLC
| GREATPOINT VENTURES INNOVATION FUND, L.P.
| ELM TREE MEDICAL, INC.
| BOOKMD, INC.
| GREATPOINT VENTURES INNOVATION PARALLEL FUND, L.P.
| ONCORESPONSE INC
| JETTI RESOURCES
| ROMAINE EMPIRE, INC.
| FLASH EQUITY LLC
| GREATPOINT VENTURES INNOVATION FUND II, L.P.
| GUIDE THERAPEUTICS, INC.
| EXTEND, INC.
| DRIVE MEDIA INC.
| SPRINGCOIN, INC.
| GPV VIM ACQUISITION COMPANY, LLC
| INVICTA MEDICAL, INC.
| SIRONA MEDICAL, INC.
| RECURRENT VENTURES LLC
| MYTHIC INC.
| BIOBOT ANALYTICS, INC.
CLIFFORD
STOCKS
EXECUTIVE OFFICER, DIRECTOR
CLIFFORD
J.
STOCKS
DIRECTOR, EXECUTIVE OFFICER
GEETA
VEMURI
DIRECTOR
ARGINETIX, INC.
| CEMPRA HOLDINGS, LLC
| CORRIDOR PHARMACEUTICALS, INC.
| GLIKNIK INC
| SYNTIMMUNE, INC.
| ONCORESPONSE INC
| AGENT CAPITAL FUND I LP
| PYXIS ONCOLOGY, INC.
| AGENT CAPITAL FUND II, LP
| VITTORIA BIOTHERAPEUTICS, INC.
| CARBON BIOSCIENCES, INC.
| CANTAI THERAPEUTICS, INC.
| AGENT CAPITAL FUND III LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

